Breast Pump Market is expected to grow significantly between 2022-2030

Breast Pump Market demand is expected to grow at a 4.6% CAGR from 2022 to 2030, reaching $2.45 billion by the end of that year, up from $1.72 billion in 2022.

The report highlights the potential factors driving the global revenue growth of the breast pump market. Breast pumps are medical devices that are used to extract breast milk from lactating women. Manual breast pumps and electrical breast pumps are the two types of breast pump products available. There are two types of electric breast pumps: single electric breast pumps and double electric breast pumps.

This report examines the total revenue generated by the sale of breast pump products, which include manual and electric breast pump devices used for breast feeding. Breast pump products are becoming increasingly important among working women around the world as women's participation in the labour force grows. The percentage of working women in workplaces around the world has been declining in recent years (46.2% in 2019 compared to 50.9% in 1990, according to "Catalyst").

Breast Pumps Market Segmentation:

By Product Type

  • Open System Breast Pumps
  • Closed System Breast Pumps

By Technology Type

  • Electric Breast Pumps
    • Single Electric Breast Pumps
    • Double Electric Breast Pumps
  • Manual Breast Pumps

 By End User

  • Homecare Settings
  • Healthcare Facilities

Key Market Players:

  • Koninklijke Philips N.V.,
  • Pigeon Corporation,
  • Newell Brands,
  • Medela Inc.,
  • Ameda Inc.,
  • Hygeia II Medical Group Inc.,
  • Bailey Medical,
  • Mayborn Group Ltd. and Linco Baby Merchandise Works Co., Ltd.
  • Others

Browse More Details@ https://www.futuremarketinsights.com/reports/breast-pump-market-122017

The market for electric breast pumps is more technologically advanced, with higher product pricing and low penetration. There are only a few global breast pump manufacturing companies in this category. Potential new entrants in the breast pump market are attempting to capture and improve their market position through novel marketing strategies such as inorganic growth. Breast pump manufacturers are expanding their product portfolio by utilising cutting-edge technology.

The availability of BPA-free breast pump products is driving breast pump adoption in both developed and emerging markets. To increase sales, breast pump manufacturers have recently begun offering bisphenol A or BPA-free breast pump products. BPA is a chemical that is used to make milk containers and feeding bottles more rigid and resistant. It has been linked to negative health effects such as neural and fertility issues. Examples of some BPA free breast pump products are Philips Avent Manual Comfort Breast Pump from Koninklijke Philips N.V. and BPA-free breast pumps by Medela, Inc.

Comments

Post a Comment

Popular posts from this blog

Targeted Therapies for Sandhoff Disease | Assessing the Global Market Landscape

Image
The global Sandhoff Disease Therapeutics Market Size is expected to be worth US$ 10 million in 2023 and US$ 17.91 million by 2033, with a CAGR of 6% from 2023 to 2033. From 2018 to 2022, the Sandhoff Disease Treatments market increased at a 4% CAGR. According to the most recent studies, Sandhoff sickness is a rare disorder that affects 1 in 1,000,000 people. The rising demand for these medications is projected to spur the discovery of novel therapies, propelling the market forward in the coming years. Gene therapy is being investigated as a potential treatment for Sandhoff disease. The therapy restores the ability to break down GM2 ganglioside by delivering a functional copy of the missing enzyme into the patient's cells. This has the potential to reduce or stop disease progression while also improving patient quality of life. Key Takeaways from the Market Study   The Sandhoff Disease Therapeutics market increased at a 4% CAGR from 2018 to 2022. From 2023 to 2033, the global Sandh
Read more

A Safer Tomorrow | Emerging Trends in Hospital-Acquired Infection Control Market

Image
According to Future Market Insights' recently released Hospital-acquired Infection Control Market analysis report, global Hospital-acquired Infection Control sales in 2023 are expected to be US$ 6.5 billion. The market is expected to increase at a CAGR of 7% between 2023 and 2033, reaching $12.7 billion by 2033. Hospitals and intensive care units are predicted to create significant income in the market, with a CAGR of 7.6%. The occurrence of hospital-acquired infections, increasing proportion of surgical procedures, growing geriatric population and increasing prevalence of chronic diseases, technological advancements in sterilisation equipment, and growing awareness of environmental and personal hygiene are the key factors driving the Hospital-acquired infection control market. The increased use of e-beam sterilisation, as well as the reintroduction of ethylene oxide sterilisation, is predicted to increase demand for hospital-acquired infection management. The percentage of treatm
Read more

Transforming Trauma | Emerging Therapies and Interventions in Post-Traumatic Stress Disorder Treatment Market

Image
According to Future Market Insights, the Post-Traumatic Stress Disorder (PTSD) Treatment Market Sales would grow at a 5% CAGR between 2023 and 2033. By 2033, the global market for post-traumatic stress disorder (PTSD) therapy is expected to reach US$ 27.37 billion. The market's growth might be attributed to the increased prevalence of PTSD globally. According to the National Centre for PTSD, approximately 7-8% of the US population will develop PTSD at some point in their lives, with greater percentages among military veterans and persons who have experienced sexual assault or other types of trauma. The COVID-19 pandemic has also been highlighted as a possible cause of PTSD, with healthcare workers, first responders, and people immediately impacted by the virus being especially vulnerable. In addition, there is a growing emphasis on using digital therapies and other non-pharmacological techniques to treat PTSD. For example, virtual reality exposure treatment (VRET) has shown potent
Read more